Le 9 novembre/November 2018

	Following a fundamental change Xanthic Biopharma Inc. has requalified for listing.

	Shares will begin trading under a new symbol “GGB” on November 13, 2018.

	Listing and disclosure documents will be available at&nbsp;www.thecse.com&nbsp;on the trading date.

	The Company is a consumer products company in the business of cultivation, processing and retailing of cannabis, tetrahydrocannabidol, cannabidiol (“CBD”) and cannabis-infused consumer products.&nbsp; Over the next 12 months, the Company intends to expand its retail and wholesale cannabis businesses as well as its CBD consumer products business through a combination of strategic partnerships, merger and acquisition activity, and organic license capture.&nbsp; The Company’s objectives are to establish retail cannabis locations, or otherwise apply for such licenses, in various states within that timeframe, pursuant to state laws.&nbsp; Such activity will focus on those certain states where cannabis has been legalized for medical and/or recreational use at the state level.

	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ________________________

	À la suite d'un changement fondamental, Xanthic Biopharma Inc. s'est requalifiée pour figurer sur la liste.

	Les actions seront négociées sous le nouveau symbole «GGB» le 13 novembre 2018.

	Les documents de cotation et d'information seront disponibles sur www.thecse.com à la date de négociation.

	La Société est une société de produits de consommation spécialisée dans la culture, la transformation et la vente au détail de cannabis, de tétrahydrocannabidol, de produits de consommation à base de cannabis et de cannabidiol («CBD»). Au cours des 12 prochains mois, la Société prévoit d’élargir ses activités liées à la vente au détail et en gros de cannabis ainsi qu’à ses activités liées aux produits de consommation DBC grâce à une combinaison de partenariats stratégiques, d’activités de fusion et acquisition et de capture de licences biologiques. Les objectifs de la société sont d’établir des points de vente de cannabis au détail, ou d’appliquer autrement pour de telles licences, dans divers États au cours de cette période, conformément à la législation de cet État. Cette activité sera centrée sur certains États où le cannabis a été légalisé à des fins médicales et / ou récréatives au niveau des États.
<table border="1" cellpadding="0" cellspacing="1" >
<tbody>
<tr>
<td>

					Issuer/Émetteur:
</td>
<td>

					Xanthic Biopharma Inc.
</td>
</tr>
<tr>
<td>

					Security Type/Titre:
</td>
<td>

					Common Shares/Actions ordinaires
</td>
</tr>
<tr>
<td>

					Symbol(s)/Symbole(s):
</td>
<td>

					GGB
</td>
</tr>
<tr>
<td>

					Number of securities issued and outstanding/&nbsp;Titres&nbsp;émis&nbsp;et en circulation:
</td>
<td>

					165 960 705
</td>
</tr>
<tr>
<td>

					Number of Securities reserved for issuance/&nbsp;Titres&nbsp;réservés&nbsp;pour&nbsp;émission:
</td>
<td>

					36 143 791
</td>
</tr>
<tr>
<td>

					CSE Sector/Catégorie:
</td>
<td>

					Life Sciences/ Sciences de la vie
</td>
</tr>
<tr>
<td>

					Consolidation
</td>
<td>

					1 new for 4 old/1 neuf pour 4 vieux
</td>
</tr>
<tr>
<td>

					CUSIP/:
</td>
<td>

					98401B203
</td>
</tr>
<tr>
<td>

					ISIN:
</td>
<td>

					CA98401B2030
</td>
</tr>
<tr>
<td>

					Old/Vieux CUSIP &amp; ISIN:
</td>
<td>

					98401B104/CA98401B1040
</td>
</tr>
<tr>
<td>

					Boardlot/Quotité:
</td>
<td>

					100
</td>
</tr>
<tr>
<td>

					Trading&nbsp;Currency/Monnaie&nbsp;de&nbsp;négociation:
</td>
<td>

					CDN$/$CDN
</td>
</tr>
<tr>
<td>

					Trading Date/Date de&nbsp;negociation:
</td>
<td>

					Le 13 novembre/November 2018
</td>
</tr>
<tr>
<td>

					Other Exchanges/Autres&nbsp;marches:
</td>
<td>

					N/A
</td>
</tr>
<tr>
<td>

					Fiscal Year&nbsp;end /Clôture&nbsp;de&nbsp;l'exercice&nbsp;financier:
</td>
<td>

					December 31/Le 31 decembre
</td>
</tr>
<tr>
<td>

					Transfer Agent/Agent des&nbsp;transferts:
</td>
<td>

					Capital Transfer Agency ULC
</td>
</tr>
</tbody>
</table>

	The Exchange is accepting Market Maker applications for GGB. Please email: <a href="mailto:Trading@theCSE.com">Trading@theCSE.com</a>

	If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	Pour toute question, pour obtenir de l’information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l’adresse:&nbsp;&nbsp;<a href="mailto:Listings@thecse.com">Listings@thecse.com</a>

	&nbsp;

Green Growth Brands Inc.

2018-1111 – Fundamental Change - Xanthic Biopharma Inc.

CSE25™

CSE Composite Index®

In this series, we delve deep into the experiences of CSE listed companies, exploring their past successes and future opportunities.

CSE Issuer Spotlight

**Follow us** for the **latest news** from the CSE

 The CSE provides a modern and efficient alternative for companies looking to access the Canadian public capital markets.

The Canadian Securities Exchange (CSE)

Learn how we streamline issuer regulation through enhanced disclosure, practical and effective regulatory oversight, and modern technology.

Listing on the CSE

Learn more about the companies we list and how to get started trading on the CSE.

Investing in Listed Companies

Learn how we lower costs, reduce complexity, and provide market making opportunities for the dealer community.

Trading on the CSE

Whether you’re an investor, business leader, or simply looking to learn more, start your journey with the CSE here.

Get Started

From announcements and market updates to in-depth interviews with company leaders - stay informed with the latest from the CSE.

Latest from the CSE

Discover newly listed companies on the CSE through our series of bite-sized interviews with company leaders.

Get to know our latest listings

Listed Company News

Market Activity

List with the CSE

Find a home for your next big idea.

Frequently Asked Questions

How does being listed on the CSE affect me as a shareholder?

Where do I get information and trade CSE listed securities?

Where can I find an RSS feed for listed company news?

Where is the CSE recognized?

Upcoming Events

join the list

Join our mailing list to receive buy-in notifications

The CSE provides a superior exchange experience by investing in our customers’ success with innovation, dedication, and passion.

Where innovation, passion, and trust intersect

We strive to be the most innovative exchange in Canada. We aim to offer unlimited global access and a customized client-centric experience while delivering the lowest cost of public capital. 

We are Canada's entrepreneurial exchange

The most searched CSE listed companies on thecse.com

Recent Quotes

Get the latest regulatory announcements from the CSE concerning its Listings Policies, Trading Rules and functionality and other important industry developments.

Notices

Get the latest information about new CSE listings, the appointment of Market Makers, market events, and other news.

Bulletins

Stay informed with CSE listed company news, providing transparency and accountability to shareholders and the public.

Company News

Stay Informed

The **total volume** traded on the CSE today is

Connect with our professionals and listing experts at industry events and conferences.